Exposure–efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s DiseaseMaria Rosario, Irving H. Fox, Jonathan French et al.|Journal of Crohn s and Colitis|2017Cited by 161
Corrigendum: Exposure—efficacy Relationships for Vedolizumab Induction Therapy in Patients with Ulcerative Colitis or Crohn’s DiseaseMaria Rosario, Irving H. Fox, Jonathan French et al.|Journal of Crohn s and Colitis|2018Cited by 122
Fecal Calprotectin Responses Following Induction Therapy With Vedolizumab in Moderate to Severe Ulcerative Colitis: A Post Hoc Analysis of GEMINI 1Walter Reinisch, Tim Wyant, Brian G. Feagan et al.|Inflammatory Bowel Diseases|2018Cited by 40
P-140 Pharmacokinetic/Pharmacodynamic Relationship and Immunogenicity of Vedolizumab in Adults with Inflammatory Bowel DiseaseMaria Rosario, Tim Wyant, Catherine Milch et al.|Inflammatory Bowel Diseases|2013Cited by 18